QRISK validation and evaluation Authors' reply

QRISK validation and evaluation Authors' reply

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Collins, G, Altman, D
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

UPDATED VERSION OF QRISK2 Authors' reply to Bird
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2012)

QRISK validation and evaluation. QRISK may be less useful.
de réir: Liew, S, et al.
Foilsithe / Cruthaithe: (2009)

QRISK validation and evaluation: QRISK may be less useful
de réir: Su, M, et al.
Foilsithe / Cruthaithe: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2009)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2010)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2012)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2012)

QRISK2-2011 predicted cardiovascular disease in adult general practice patients
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2012)

Authors' reply to Bird.
de réir: Collins, G, et al.
Foilsithe / Cruthaithe: (2012)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
de réir: Manpreet Singh, et al.
Foilsithe / Cruthaithe: (2022-07-01)

The authors reply
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (2009)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
de réir: Parsons, RE, et al.
Foilsithe / Cruthaithe: (2023)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
de réir: Hippisley-Cox, J, et al.
Foilsithe / Cruthaithe: (2017)

Authors' reply [5]
de réir: Chen, Z, et al.
Foilsithe / Cruthaithe: (2006)

Assessment of QRISK3 Score in Normoglycaemic, Prediabetic and Diabetic Subjects: An Observational Study
de réir: Aayushee Rao, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Authors' reply:
de réir: Garety, P, et al.
Foilsithe / Cruthaithe: (2008)

Fetal growth and ethnic variation--authors' reply.
de réir: Villar, J, et al.
Foilsithe / Cruthaithe: (2014)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.
de réir: Mónica Vázquez-Del Mercado, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Author Reply
de réir: Krishna G Seshadri
Foilsithe / Cruthaithe: (2014-01-01)

Statins and diabetes - Authors' reply
de réir: Kearney, P, et al.
Foilsithe / Cruthaithe: (2008)

Author′s Reply
de réir: Farid E Stephan, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Author's reply
de réir: Freeman, D
Foilsithe / Cruthaithe: (2008)

Safety and efficacy of statins - Authors' reply
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (2017)

Reply to author
de réir: Thao, L, et al.
Foilsithe / Cruthaithe: (2018)

Authors' Reply
de réir: Madhai L Teegala, et al.
Foilsithe / Cruthaithe: (2018-07-01)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
de réir: V. Erbasan, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Authors′ reply
de réir: Vinita G Rao, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Authors' reply.
de réir: Garety, P, et al.
Foilsithe / Cruthaithe: (2014)

Authors' Reply
de réir: P McKenna, et al.
Foilsithe / Cruthaithe: (2008-04-01)

Reply of the Authors
de réir: Jessica K. Wu, B.S, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Authors′ Reply
de réir: Ramesh Kekunnaya, et al.
Foilsithe / Cruthaithe: (2014-01-01)

The Authors' reply.
de réir: Lasserson, D, et al.
Foilsithe / Cruthaithe: (2011)

The authors reply
de réir: David Vlahov, et al.

Author's Reply
de réir: Georgios D Panos, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Authors' Reply
de réir: SV Vaidya, et al.
Foilsithe / Cruthaithe: (2004-06-01)

Authors' reply
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2013)